NCT02740621|Completed
The Impact of Opioids in Coronary Heart Disease
MIOP/TRAPS
Evaluation of Past Medications in Patients With Coronary Heart Disease and Patients Hospitalized for a Non-cardiac Reason
Loading search results
MIOP/TRAPS
Evaluation of Past Medications in Patients With Coronary Heart Disease and Patients Hospitalized for a Non-cardiac Reason
Sponsor study identifier
observational
750
1 country
1
Study Start
January 2016
Actual (reported)Primary Completion
January 2017
Actual (reported)Study Completion
August 2017
Actual (reported)In this study, the risk of opioid medications on coronary heart disease in adults is investigated. Patients with the necessity of a coronary angiography and control patients with a non-cardiac disease of the same hospital are inquired with a standardized questionnaire about demographic and clinical risk factors for heart attack. An impact of opioid medications on coronary heart disease is hypothesised (MIOP). In addition, all patients with coronary angiography should be consulted twice (after 3 and 6 months) to find out how many of these patients have developed a refractory angina pectoris (TRAPS).
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
August 2017
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 2016
Actual (reported)March 30, 2016
Actual (reported)April 15, 2016
Actual (reported)January 2017
Actual (reported)August 2017
Actual (reported)Number of patients with opioid treatment (WHO II/ WHO III) within the last 10 years before present hospitalization, Interview with standardized CRF
Standardized assessment of opioid medications taken before hospital admission to evaluate the impact of opioids in coronary heart disease. Exact doses, substances and intake habits are inquired.
20 minutes
Number of patients with refractory angina pectoris, Interview with standardized CRF
Standardized assessment of angina pectoris symptoms and treatments to evaluate a refractory angina pectoris. Changes of their medications are inquired twice.
30 minutes
coronary angiography with finding coronary heart disease currently no cancer 40 years or older
coronary angiography with exclusion coronary heart disease or other patients with non-cardiac diseases currently no cancer 40 years or older
hospitalized patients in University Hospital
Bergmannsheil department of pain therapy
Bochum, North Rhine-Westphalia, 44789, Germany
750 participants (actual enrollment reported by the registry).
First Submitted
March 30, 2016
First Posted
April 15, 2016
Study Start
January 2016
Actual (reported)Adipose Tissue and Inflammation in Coronary Heart Disease
Contact the study team to confirm eligibility.
Primary Completion
January 2017
Actual (reported)Study Completion
August 2017
Actual (reported)Last Updated
April 11, 2018
Record last verified: 2018-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: